Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States.
about
Seroadaptive practices: association with HIV acquisition among HIV-negative men who have sex with menAge and sex or gender (sex/gender) and HIV vaccine preparedness.Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical preventionAssessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study.Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials.Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs.Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies.Using social networks to recruit an HIV vaccine preparedness cohortHIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries.Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City.Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team.In "Step" with HIV Vaccines? A Content Analysis of Local Recruitment Campaigns for an International HIV Vaccine StudyPromoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement?Knowledge and attitudes towards HIV vaccines among Soweto adolescents.Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodiesThe benefits of participatory methodologies to develop effective community dialogue in the context of a microbicide trial feasibility study in Mwanza, Tanzania.Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa?What leads Indians to participate in clinical trials? A meta-analysis of qualitative studiesBuilding and testing an effective HIV vaccine.Decisions to participate in research: views of underserved minority drug users with or at risk for HIVTheoretical model of critical issues in informed consent in HIV vaccine trialsAre young injection drug users ready and willing to participate in preventive HCV vaccine trials?A randomized trial of enhanced HIV risk-reduction and vaccine trial education interventions among HIV-negative, high-risk women who use noninjection drugs: the UNITY studyEnrollment in YFV Vaccine Trial: An Evaluation of Recruitment Outcomes Associated with a Randomized Controlled Double-Blind Trial of a Live Attenuated Yellow Fever Vaccine.HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria.Fishermen as a Suitable Population for HIV Intervention TrialsProject VOGUE: A partnership for increasing HIV knowledge and HIV vaccine trial awareness among House Ball leaders in Western New York.Recruitment of men who have sex with men for large HIV intervention trials: analysis of the EXPLORE Study recruitment effort.Selectively willing and conditionally able: HIV vaccine trial participation among women at "high risk" of HIV infection.Willingness to participate in HIV-1 vaccine trials among young Thai menDevelopment and evaluation of a web-based assent for adolescents considering an HIV vaccine trial.Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa.Engaging members of African American and Latino communities in preventive HIV vaccine trials.Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-positive injection drug users.Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in UgandaWillingness to participate in HIV/STD prevention activities among Chinese rural-to-urban migrants.Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.Factors associated with past research participation among low-income persons living with HIV.Recruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trialsCharacteristics of female sex workers in southern India willing and unwilling to participate in a placebo gel trial
P2860
Q28484220-6A29794E-233D-4875-9ECB-5BCA870CBD0EQ30202232-557CA811-3E6B-4F2F-A1DB-E5CF050CA781Q30206105-6386AA18-32B7-461D-886B-6CE9DF157A3BQ30208996-3085BD9A-5A8F-4AD7-8CD9-89B35CBCC7EAQ30223510-32AFFB2C-9A4A-4FB1-B581-8E8A60F83683Q30223906-010F9CFE-6172-43D8-A54A-6CB687D333CCQ30226501-89B2BB7C-776F-4A6B-92F4-6A7DC96502ADQ30227795-4555DF7F-5671-4F9A-844B-887E0E440A2DQ30229401-1ED43853-795A-4405-8722-2D54F8D59A01Q30233658-E1CF57DD-3D38-429A-9BF3-AF31233241EAQ30233662-FDA6B6B0-E824-43D7-A6CD-0A8A4E74229AQ30378981-9E8E3C58-0893-445F-A3EA-D09CC989D4C8Q30392323-A0493BDA-6436-4566-8F8B-1C5849C989D3Q30847508-D728F976-ABFE-42F6-B57A-D817E64B954EQ33233776-CF7F332E-3745-4541-B8BA-3274A093368FQ33294097-8BCC0DE6-3814-45E4-B930-6BC4AFB9C90FQ33586189-8DC912BA-4594-4BB4-9067-466679312995Q33588531-5C9A89F4-FA60-4E23-BB89-B2165F784E2EQ33820028-0E210BFF-7126-42DB-9AA3-AA9DFEC04A65Q33865695-8705D423-99CD-4D29-95CD-30F0CEBEC19DQ34005683-9F14BCC7-23DB-49E2-8F81-D9C702529712Q34115061-64414D2E-DE08-4490-A64B-19F787BE056AQ34133358-1418AC8D-5C3B-4B1D-AD48-FFC8669AA9F9Q34159806-653FDFAD-E354-42BB-BEEE-56EE8664D8E7Q34313611-14E14F78-A0B9-436D-BB78-FDB3CC8BFCAFQ34730059-233C0DC3-31EB-48C5-BCA2-039D74361E8EQ35019252-7FE59ADE-9BC4-4D2B-93F9-0CB3E50CF3D5Q35044939-BBD4C297-7B0C-4CA6-B84E-54C96A55480FQ35187935-4D3683E0-1AC7-4BF6-BAE1-A82673B05406Q35528853-A400E9DC-7A84-4E49-B72C-485DC76C11EDQ35587440-4A5B72B3-6E03-42A7-AB61-5D4EDB800171Q35698044-3AC6B9DE-B94B-4BF9-89A1-092EED3E2632Q35736408-9E5FED6E-BBDE-45AD-995E-D17F0B5191F7Q35791291-2A2F2480-82A2-4A9A-AEC1-EB73DED10D01Q35863340-F9998E48-D973-4482-86F3-1961356106BCQ35973177-21AB4E24-E8E4-42C7-A8A1-3068F980DA83Q35985816-B099DBB1-D04F-490D-8462-510517217C54Q36291871-B5EB2362-670F-4CA0-966D-BE87629102FAQ36582002-640A5AAD-3D05-42A8-AAB1-F0E780B7F5ECQ36777020-C848019A-091E-4070-8DFB-75D729B970AA
P2860
Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Readiness of high-risk populat ...... y trials in the United States.
@ast
Readiness of high-risk populat ...... y trials in the United States.
@en
type
label
Readiness of high-risk populat ...... y trials in the United States.
@ast
Readiness of high-risk populat ...... y trials in the United States.
@en
prefLabel
Readiness of high-risk populat ...... y trials in the United States.
@ast
Readiness of high-risk populat ...... y trials in the United States.
@en
P2093
P1433
P1476
Readiness of high-risk populat ...... y trials in the United States.
@en
P2093
Buchbinder S
Douglas JM
Heagerty P
P304
P356
10.1097/00002030-199807000-00015
P407
P577
1998-05-01T00:00:00Z